216 related articles for article (PubMed ID: 29449331)
1. Lipid-Lowering Therapy With Ezetimibe Decreases Spontaneous Atherothrombotic Occlusions in a Rabbit Model of Plaque Erosion: A Role of Serum Oxysterols.
Honda K; Matoba T; Antoku Y; Koga JI; Ichi I; Nakano K; Tsutsui H; Egashira K
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):757-771. PubMed ID: 29449331
[TBL] [Abstract][Full Text] [Related]
2. Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect.
Gómez-Garre D; Muñoz-Pacheco P; González-Rubio ML; Aragoncillo P; Granados R; Fernández-Cruz A
Br J Pharmacol; 2009 Apr; 156(8):1218-27. PubMed ID: 19222481
[TBL] [Abstract][Full Text] [Related]
3. Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial.
Nakano Y; Yamamoto M; Matoba T; Katsuki S; Nakashiro S; Takase S; Akiyama Y; Nagata T; Mukai Y; Inoue S; Oi K; Higo T; Takemoto M; Suematsu N; Eshima K; Miyata K; Usui M; Sadamatsu K; Kadokami T; Hironaga K; Ichi I; Todaka K; Kishimoto J; Tsutsui H
J Atheroscler Thromb; 2023 Aug; 30(8):907-918. PubMed ID: 36450458
[TBL] [Abstract][Full Text] [Related]
4. Dietary cholesterol oxidation products accelerate plaque destabilization and rupture associated with monocyte infiltration/activation via the MCP-1-CCR2 pathway in mouse brachiocephalic arteries: therapeutic effects of ezetimibe.
Sato K; Nakano K; Katsuki S; Matoba T; Osada K; Sawamura T; Sunagawa K; Egashira K
J Atheroscler Thromb; 2012; 19(11):986-98. PubMed ID: 22785139
[TBL] [Abstract][Full Text] [Related]
5. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.
Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M
J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427
[TBL] [Abstract][Full Text] [Related]
6. Vascular wall hypoxia promotes arterial thrombus formation via augmentation of vascular thrombogenicity.
Matsuura Y; Yamashita A; Iwakiri T; Sugita C; Okuyama N; Kitamura K; Asada Y
Thromb Haemost; 2015 Jul; 114(1):158-72. PubMed ID: 25833755
[TBL] [Abstract][Full Text] [Related]
7. Antihypercholesterolemic and antioxidant efficacies of zerumbone on the formation, development, and establishment of atherosclerosis in cholesterol-fed rabbits.
Hemn HO; Noordin MM; Rahman HS; Hazilawati H; Zuki A; Chartrand MS
Drug Des Devel Ther; 2015; 9():4173-208. PubMed ID: 26347047
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the effects of monotherapy with rosuvastatin, atorvastatin or ezetimibe versus combination treatment with rosuvastatin-ezetimibe and atorvastatin-ezetimibe on the integrity of vascular endothelial cells damaged by oxidized cholesterol.
Niedzielski M; Broncel M; Gorzelak-Pabiś P; Woźniak E
PLoS One; 2021; 16(9):e0256996. PubMed ID: 34492054
[TBL] [Abstract][Full Text] [Related]
9. Ezetimibe - new anti-atherogenic properties?
Tomkin GH
Br J Pharmacol; 2009 Apr; 156(8):1216-7. PubMed ID: 19751315
[TBL] [Abstract][Full Text] [Related]
10. Cholesteryl ester transfer protein inhibition enhances endothelial repair and improves endothelial function in the rabbit.
Wu BJ; Shrestha S; Ong KL; Johns D; Hou L; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):628-36. PubMed ID: 25633313
[TBL] [Abstract][Full Text] [Related]
11. Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography.
Patel R; Janoudi A; Vedre A; Aziz K; Tamhane U; Rubinstein J; Abela OG; Berger K; Abela GS
Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2007-14. PubMed ID: 21817102
[TBL] [Abstract][Full Text] [Related]
12. An animal model of atherosclerotic plaque disruption and thrombosis in rabbit using pharmacological triggering to plaques induced by perivascular collar placement.
Sun X; Cao W; Cui J; Wang L; Ma L; Wang T; Peng C; Tian Z; Shi S; Guo S; Tian Y
Cardiovasc Pathol; 2013; 22(4):264-9. PubMed ID: 23452613
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte membrane cholesterol and lipid core growth in a rabbit model of atherosclerosis: modulatory effects of rosuvastatin.
Tziakas D; Chalikias G; Kapelouzou A; Tentes I; Schäfer K; Karayannakos P; Kostakis A; Boudoulas H; Konstantinides S
Int J Cardiol; 2013 Dec; 170(2):173-81. PubMed ID: 24215985
[TBL] [Abstract][Full Text] [Related]
14. Effects of ezetimibe on atherosclerosis in preclinical models.
Davis HR; Lowe RS; Neff DR
Atherosclerosis; 2011 Apr; 215(2):266-78. PubMed ID: 21397230
[TBL] [Abstract][Full Text] [Related]
15. The effect of lipid-lowering therapies on the pro-inflammatory and anti-inflammatory properties of vascular endothelial cells.
Woźniak E; Broncel M; Niedzielski M; Woźniak A; Gorzelak-Pabiś P
PLoS One; 2023; 18(2):e0280741. PubMed ID: 36753488
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 18 binding protein (IL18-BP) inhibits neointimal hyperplasia after balloon injury in an atherosclerotic rabbit model.
Li JM; Eslami MH; Rohrer MJ; Dargon P; Joris I; Hendricks G; Baker S; Cutler BS
J Vasc Surg; 2008 May; 47(5):1048-57. PubMed ID: 18455646
[TBL] [Abstract][Full Text] [Related]
17. Pravastatin inhibits plaque rupture and subsequent thrombus formation in atherosclerotic rabbits with hyperlipidemia.
Wu G; Xie Q; Xu L; Jiang H; Huang Z; Huang C
Chem Pharm Bull (Tokyo); 2013; 61(2):121-4. PubMed ID: 23207681
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of co-administration of atorvastatin and endothelin-1 receptor antagonist on the progression of atherosclerosis in rabbit.
Sun Y; Liu J; Yang B; Sai X; Li T; Wang D; Zhou R
APMIS; 2014 Jun; 122(6):556-64. PubMed ID: 24164644
[TBL] [Abstract][Full Text] [Related]
19. Effect of combination therapy of ezetimibe and rosuvastatin on regression of coronary atherosclerosis in patients with coronary artery disease.
Masuda J; Tanigawa T; Yamada T; Nishimura Y; Sasou T; Nakata T; Sawai T; Fujimoto N; Dohi K; Miyahara M; Nishikawa M; Nakamura M; Ito M
Int Heart J; 2015 May; 56(3):278-85. PubMed ID: 25902885
[TBL] [Abstract][Full Text] [Related]
20. Effect of rosuvastatin on atherosclerotic plaque stability: An intravascular ultrasound elastography study.
Li Z; Wang L; Hu X; Zhang P; Chen Y; Liu X; Xu M; Zhang Y; Zhang M
Atherosclerosis; 2016 May; 248():27-35. PubMed ID: 26978584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
